Meyer Handelman Company’s Edwards Lifesciences EW Stock Holding History

Meyer Handelman Company’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.02M	Hold	25,200	–	–	0.06%	126
2025 Q4	$2.15M	Sell	25,200 -6,378	-20%	-$523K	0.07%	130
2025 Q3	$2.46M	Sell	31,578 -1,500	-5%	-$117K	0.08%	124
2025 Q2	$2.59M	Hold	33,078	–	–	0.09%	122
2025 Q1	$2.4M	Sell	33,078 -1,530	-4%	-$110K	0.08%	128
2024 Q4	$2.56M	Hold	34,608	–	–	0.09%	124
2024 Q3	$2.28M	Sell	34,608 -4,500	-12%	-$327K	0.08%	132
2024 Q2	$3.61M	Hold	39,108	–	–	0.13%	114
2024 Q1	$3.74M	Buy	39,108 +3,972	+11%	+$334K	0.13%	113
2023 Q4	$2.68M	Sell	35,136 -4,500	-11%	-$313K	0.1%	125
2023 Q3	$2.75M	Buy	39,636 +9,300	+31%	+$747K	0.11%	123
2023 Q2	$2.86M	Buy	30,336 +6,408	+27%	+$557K	0.12%	122
2023 Q1	$1.98M	Sell	23,928 -6,408	-21%	-$504K	0.08%	131
2022 Q4	$2.26M	Hold	30,336	–	–	0.09%	125
2022 Q3	$2.51M	Hold	30,336	–	–	0.12%	122
2022 Q2	$2.88M	Hold	30,336	–	–	0.12%	119
2022 Q1	$3.57M	Hold	30,336	–	–	0.14%	115
2021 Q4	$3.93M	Buy	30,336 +5,928	+24%	+$691K	0.15%	112
2021 Q3	$2.76M	Hold	24,408	–	–	0.11%	120
2021 Q2	$2.53M	Hold	24,408	–	–	0.1%	121
2021 Q1	$2.04M	Buy	24,408 +6,408	+36%	+$542K	0.08%	123
2020 Q4	$1.64M	Buy	18,000 +4,800	+36%	+$398K	0.07%	126
2020 Q3	$1.05M	Hold	13,200	–	–	0.05%	133
2020 Q2	$912K	Hold	13,200	–	–	0.05%	138
2020 Q1	$830K	Hold	13,200	–	–	0.05%	135
2019 Q4	$1.03M	Hold	13,200	–	–	0.05%	137
2019 Q3	$968K	Hold	13,200	–	–	0.05%	136
2019 Q2	$813K	Hold	13,200	–	–	0.04%	144
2019 Q1	$764K	Hold	13,200	–	–	0.04%	143
2018 Q4	$674K	Hold	13,200	–	–	0.04%	141
2018 Q3	$766K	Hold	13,200	–	–	0.04%	147
2018 Q2	$641K	Hold	13,200	–	–	0.03%	153
2018 Q1	$614K	Hold	13,200	–	–	0.03%	153
2017 Q4	$496K	Hold	13,200	–	–	0.02%	162
2017 Q3	$481K	Hold	13,200	–	–	0.02%	159
2017 Q2	$520K	Hold	13,200	–	–	0.02%	154
2017 Q1	$414K	Hold	13,200	–	–	0.02%	161
2016 Q4	$412K	Hold	13,200	–	–	0.02%	161
2016 Q3	$530K	Hold	13,200	–	–	0.02%	148
2016 Q2	$439K	Hold	13,200	–	–	0.02%	155
2016 Q1	$388K	Hold	13,200	–	–	0.02%	168
2015 Q4	$348K	Hold	13,200	–	–	0.02%	170
2015 Q3	$313K	Hold	13,200	–	–	0.02%	177
2015 Q2	$313K	Hold	13,200	–	–	0.01%	180
2015 Q1	$313K	Buy	+13,200	New	+$296K	0.01%	182

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Meyer Handelman Company's EW Position: Q1 2026 in Review

Meyer Handelman Company held its Edwards Lifesciences (EW) position steady in Q1 2026 at 25,200 shares worth $2.02M. The position accounts for 0.06% of the portfolio, ranked #126.

Meyer Handelman Company first reported a position in EW in Q1 2015 and has held it in 45 quarters since. The position peaked at $3.93M in Q4 2021. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Meyer Handelman Company held 25,200 shares of Edwards Lifesciences worth $2.02M as of Q1 2026.
Meyer Handelman Company left its Edwards Lifesciences share count unchanged in Q1 2026.
Edwards Lifesciences made up 0.06% of Meyer Handelman Company's portfolio in Q1 2026, its #126 holding.
Meyer Handelman Company first reported a position in Edwards Lifesciences in Q1 2015 and has held it in 45 quarters since.
Meyer Handelman Company's Edwards Lifesciences position peaked at $3.93M in Q4 2021.
1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Meyer Handelman Company's 13F filing for Q1 2026, filed 20 Apr 2026.